SUN VALLEY, Calif., Aug. 18 /PRNewswire-FirstCall/ -- XTend Medical Corporation , a company that delivers cutting-edge telemedicine solutions to the healthcare industry, has secured up to $1 million dollars in financing for their upcoming implementation of their Remote Diabetic Monitoring Programs with several large U.S. and European Health Organizations.
The company released the following statement:
“XTend Medical recently secured a $1 million dollar financing package designed to assist us in the implementation of our Remote Patient Monitoring System for Diabetes. This allows us to focus 100% on insuring the pending closure of several contracts over the next 30 days will be done with less financial strain on the company and allows us to purchase our products on favorable pricing thereby increasing our profit margins for the company. We’ve worked very hard over the last six months in marketing our products globally and this financing creates the opportunity for the company to focus on gaining additional contracts here in the U.S. and in the European Market. Our Remote Diabetic Patient Monitoring Program has been well received thus far with the patients and physicians we currently work with and we’ve had several large health organizations both here in the U.S. and in Europe express a deep interest in starting programs for their patients. We’re poised and ready to capitalize on these opportunities and should see a significant increase in patients on the program by the end of the year.” stated Mr. Paul D. Lisenby, CEO of XTend Medical
For any healthcare agency of physician group that would like to find more about the how XTend can assist in your management of diabetic patients, please visit the company website at http://www.xtendmedical.com or email us at info@xtendmedical.com
About XTend Medical: XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. XTend has developed a complete Remote Diabetic Patient Monitoring System that is currently being used by physicians and other healthcare agencies throughout the U.S. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. For more information, please visit their website at http://www.xtendmedical.com
Safe Harbor
This press release contains or may contain forward-looking statements such as statements regarding the Company’s growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.
CONTACT: Investor Relations, +1-817-812-2105, FutureTechIR for XTend
Medical Corporation
Web site: http://www.xtendmedical.com/
